TY - JOUR AU - Beaglehole, R. AU - Yach, D. PY - 2003 DA - 2003// TI - Globalisation and the prevention and control of non-communicable disease: the neglected chronic diseases of adults JO - Lancet VL - 362 UR - https://doi.org/10.1016/S0140-6736(03)14335-8 DO - 10.1016/S0140-6736(03)14335-8 ID - Beaglehole2003 ER - TY - JOUR AU - Dhinqra, D. AU - Lamba, D. PY - 2014 DA - 2014// TI - Antihyperlipidemic activity of Aloe succotrina in rats: possibly mediated by inhibition of HMG-CoA Reductase JO - ISRN Pharmacol ID - Dhinqra2014 ER - TY - JOUR AU - Kolovou, G. D. AU - Anaqnostopoulou, K. K. PY - 2005 DA - 2005// TI - Pathophysiology of dyslipidaemia in the metabolic syndrome JO - Postgrad Med J VL - 81 UR - https://doi.org/10.1136/pgmj.2004.025601 DO - 10.1136/pgmj.2004.025601 ID - Kolovou2005 ER - TY - JOUR AU - Izadpanah, R. AU - Schächtele, D. J. PY - 2015 DA - 2015// TI - The impact of statins on biological characteristics of stem cells provides a novel explanation for their pleiotropic beneficial and adverse clinical effects JO - Am J Physiol Cell Physiol VL - 309 UR - https://doi.org/10.1152/ajpcell.00406.2014 DO - 10.1152/ajpcell.00406.2014 ID - Izadpanah2015 ER - TY - JOUR AU - Bays, H. PY - 2006 DA - 2006// TI - Statin safety: an overview and assessment of the data--2005 JO - Am J Cardiol VL - 97 UR - https://doi.org/10.1016/j.amjcard.2005.12.006 DO - 10.1016/j.amjcard.2005.12.006 ID - Bays2006 ER - TY - JOUR AU - Hamann, P. D. AU - Cooper, R. G. PY - 2013 DA - 2013// TI - Statin-induced necrotizing myositis - a discrete autoimmune entity within the "statin-induced myopathy spectrum" JO - Autoimmun Rev VL - 12 UR - https://doi.org/10.1016/j.autrev.2013.07.001 DO - 10.1016/j.autrev.2013.07.001 ID - Hamann2013 ER - TY - JOUR AU - Murinson, B. B. AU - Hauqhey, N. J. PY - 2012 DA - 2012// TI - Selected statins produce rapid spinal motor neuron loss in vitro JO - BMC Musculoskelet Disord VL - 13 UR - https://doi.org/10.1186/1471-2474-13-100 DO - 10.1186/1471-2474-13-100 ID - Murinson2012 ER - TY - JOUR AU - Sattar, N. AU - Preiss, D. PY - 2010 DA - 2010// TI - Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials JO - Lancet VL - 375 UR - https://doi.org/10.1016/S0140-6736(09)61965-6 DO - 10.1016/S0140-6736(09)61965-6 ID - Sattar2010 ER - TY - JOUR AU - Tierney, E. F. AU - Thurman, D. J. PY - 2013 DA - 2013// TI - Association of statin use with peripheral neuropathy in the U.S. population 40 years of age or older JO - J Diabetes VL - 5 UR - https://doi.org/10.1111/1753-0407.12013 DO - 10.1111/1753-0407.12013 ID - Tierney2013 ER - TY - JOUR AU - Yin, J. AU - Zhang, H. PY - 2008 DA - 2008// TI - Traditional Chinese medicine in treatment of metabolic syndrome JO - Endocr Metab Immune Disord Drug Targets VL - 8 UR - https://doi.org/10.2174/187153008784534330 DO - 10.2174/187153008784534330 ID - Yin2008 ER - TY - JOUR AU - Usui, T. PY - 2006 DA - 2006// TI - Pharmaceutical prospects of phytoestrogens JO - Endocr J VL - 53 UR - https://doi.org/10.1507/endocrj.53.7 DO - 10.1507/endocrj.53.7 ID - Usui2006 ER - TY - JOUR AU - Patel, R. P. AU - Barnes, S. PY - 2010 DA - 2010// TI - Isoflavones and PPAR signaling: a critical target in cardiovascular, metastatic, and metabolic disease JO - PPAR Res ID - Patel2010 ER - TY - JOUR AU - Yalniz, M. AU - Bahcecioglu, I. H. PY - 2007 DA - 2007// TI - Preventive role of genistein in an experimental non-alcoholic steatohepatitis model JO - J Gastroenterol Hepatol VL - 22 UR - https://doi.org/10.1111/j.1440-1746.2006.04681.x DO - 10.1111/j.1440-1746.2006.04681.x ID - Yalniz2007 ER - TY - JOUR AU - Pakalapati, G. AU - Li, L. PY - 2009 DA - 2009// TI - Influence of red clover (Trifolium pratense) isoflavones on gene and protein expression profiles in liver of ovariectomized rats JO - Phytomedicine VL - 16 UR - https://doi.org/10.1016/j.phymed.2009.03.003 DO - 10.1016/j.phymed.2009.03.003 ID - Pakalapati2009 ER - TY - JOUR AU - Evans, R. M. PY - 2005 DA - 2005// TI - The nuclear receptor superfamily: a rosetta stone for physiology JO - Mol Endocrinol VL - 19 UR - https://doi.org/10.1210/me.2005-0046 DO - 10.1210/me.2005-0046 ID - Evans2005 ER - TY - JOUR AU - Shen, P. AU - Liu, M. H. PY - 2006 DA - 2006// TI - Differential effects of isoflavones, from Astragalus Membranaceus and Pueraria Thomsonii, on the activation of PPARalpha, PPARgamma, and adipocyte differentiation in vitro JO - J Nutr VL - 136 ID - Shen2006 ER - TY - JOUR AU - Kan, C. F. AU - Singh, A. B. PY - 1851 DA - 1851// TI - PPARδ activation induces hepatic long-chain acyl-CoA synthetase 4 expression in vivo and in vitro JO - Biochim Biophys Acta VL - 2015 ID - Kan1851 ER - TY - JOUR AU - Moghadasian, M. H. PY - 2002 DA - 2002// TI - Experimental atherosclerosis: a historical overview JO - Life Sci VL - 70 UR - https://doi.org/10.1016/S0024-3205(01)01479-5 DO - 10.1016/S0024-3205(01)01479-5 ID - Moghadasian2002 ER - TY - JOUR AU - Bishop, R. W. PY - 1992 DA - 1992// TI - Structure of the hamster low density lipoprotein receptor gene JO - J Lipid Res VL - 33 ID - Bishop1992 ER - TY - JOUR AU - Chen, W. AU - Fan, S. PY - 2014 DA - 2014// TI - Novel PPAR pan agonist, ZBH ameliorates hyperlipidemia and insulin resistance in high fat diet induced hyperlipidemic hamster JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0096056 DO - 10.1371/journal.pone.0096056 ID - Chen2014 ER - TY - JOUR AU - Sullivan, M. P. AU - Cerda, J. J. PY - 1993 DA - 1993// TI - The gerbil, hamster, and guinea pig as rodent models for hyperlipidemia JO - Lab Anim Sci VL - 43 ID - Sullivan1993 ER - TY - JOUR AU - Sima, A. AU - Stancu, C. PY - 2001 DA - 2001// TI - The hyperlipemic hamster - a model for testing the anti-atherogenic effect of amlodipine JO - J Cell Mol Med VL - 5 UR - https://doi.org/10.1111/j.1582-4934.2001.tb00148.x DO - 10.1111/j.1582-4934.2001.tb00148.x ID - Sima2001 ER - TY - JOUR AU - Lim, M. K. AU - Ku, S. K. PY - 2015 DA - 2015// TI - Effect of polycan, a β-glucan originating from Aureobasidium, on a high-fat diet-induced hyperlipemic hamster model JO - Exp Ther Med VL - 9 ID - Lim2015 ER - TY - JOUR AU - Huang, W. C. AU - Chen, Y. M. PY - 2015 DA - 2015// TI - Hypolipidemic effects and safety of lactobacillus reuteri 263 in a hamster model of hyperlipidemia JO - Nutrients VL - 7 UR - https://doi.org/10.3390/nu7053767 DO - 10.3390/nu7053767 ID - Huang2015 ER - TY - JOUR AU - Chen, W. C. AU - Huang, W. C. PY - 2014 DA - 2014// TI - Whey protein improves exercise performance and biochemical profiles in trained mice JO - Med Sci Sports Exerc VL - 46 UR - https://doi.org/10.1249/MSS.0000000000000272 DO - 10.1249/MSS.0000000000000272 ID - Chen2014 ER - TY - JOUR AU - Fishbein, M. C. PY - 2010 DA - 2010// TI - The vulnerable and unstable atherosclerotic plaque JO - Cardiovasc Pathol VL - 19 UR - https://doi.org/10.1016/j.carpath.2008.08.004 DO - 10.1016/j.carpath.2008.08.004 ID - Fishbein2010 ER - TY - JOUR AU - Tenenbaum, A. AU - Fisman, E. Z. PY - 2012 DA - 2012// TI - Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction JO - Cardiovasc Diabetol VL - 11 UR - https://doi.org/10.1186/1475-2840-11-125 DO - 10.1186/1475-2840-11-125 ID - Tenenbaum2012 ER - TY - JOUR AU - Corti, R. AU - Fuster, V. PY - 2002 DA - 2002// TI - Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years’ follow-up by high-resolution noninvasive magnetic resonance imaging JO - Circulation VL - 106 UR - https://doi.org/10.1161/01.CIR.0000041255.88750.F0 DO - 10.1161/01.CIR.0000041255.88750.F0 ID - Corti2002 ER - TY - JOUR AU - Pucci, A. AU - Sheiban, I. PY - 2007 DA - 2007// TI - In vivo coronary plaque histology in patients with stable and acute coronary syndromes: relationships with hyperlipidemic status and statin treatment JO - Atherosclerosis VL - 194 UR - https://doi.org/10.1016/j.atherosclerosis.2006.07.026 DO - 10.1016/j.atherosclerosis.2006.07.026 ID - Pucci2007 ER - TY - JOUR AU - Crisby, M. AU - Nordin-Fredriksson, G. PY - 2001 DA - 2001// TI - Pravastatin treatment increases collagen content and decreases lipid content, infammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization JO - Circulation VL - 103 UR - https://doi.org/10.1161/01.CIR.103.7.926 DO - 10.1161/01.CIR.103.7.926 ID - Crisby2001 ER - TY - JOUR AU - Wang, P. AU - Xu, S. PY - 2014 DA - 2014// TI - Salvianolic acid B inhibited PPARγ expression and attenuated weight gain in mice with high-fat diet-induced obesity JO - Cell Physiol Biochem VL - 34 UR - https://doi.org/10.1159/000362999 DO - 10.1159/000362999 ID - Wang2014 ER - TY - JOUR AU - Zou, C. AU - Shao, J. PY - 2008 DA - 2008// TI - Role of adipocytokines in obesity-associated insulin resistance JO - J Nutr Biochem VL - 19 UR - https://doi.org/10.1016/j.jnutbio.2007.06.006 DO - 10.1016/j.jnutbio.2007.06.006 ID - Zou2008 ER - TY - JOUR AU - Mezei, O. AU - Banz, W. J. PY - 2003 DA - 2003// TI - Soy Isoflavones exert Antidiabetic and Hypolipidemic effects through the PPAR pathways in obese Zucker rats and Murine RAW 264.7 cells JO - J Nutr VL - 133 ID - Mezei2003 ER - TY - JOUR AU - Michalik, L. AU - Auwerx, J. PY - 2006 DA - 2006// TI - International Union of Pharmacology. LXI. Peroxisome Proliferator-activated receptors JO - Pharmacol Rev VL - 58 UR - https://doi.org/10.1124/pr.58.4.5 DO - 10.1124/pr.58.4.5 ID - Michalik2006 ER - TY - JOUR AU - Han, L. AU - Li, M. PY - 2012 DA - 2012// TI - Atorvastatin may delay cardiac aging by upregulating peroxisome proliferator-activated receptors in rats JO - Pharmacology VL - 89 UR - https://doi.org/10.1159/000335783 DO - 10.1159/000335783 ID - Han2012 ER - TY - JOUR AU - Sheng, L. AU - Yang, X. PY - 2015 DA - 2015// TI - Effect of Atorvastatin on expression of Peroxisome Proliferator-activated receptor Beta/delta in Angiotensin II-induced hypertrophic myocardial cells in vitro JO - Chin Med Sci J VL - 30 UR - https://doi.org/10.1016/S1001-9294(16)30008-6 DO - 10.1016/S1001-9294(16)30008-6 ID - Sheng2015 ER - TY - JOUR AU - Zhao, J. AU - Cheng, Q. PY - 2016 DA - 2016// TI - Atorvastatin improves pathological changes in the aged kidney by upregulating peroxisome proliferator-activated receptor expression and reducing matrix metalloproteinase-9 and transforming growth factor-β1 levels JO - Exp Gerontol VL - 74 UR - https://doi.org/10.1016/j.exger.2015.12.004 DO - 10.1016/j.exger.2015.12.004 ID - Zhao2016 ER - TY - JOUR AU - Contreras, A. V. AU - Torres, N. PY - 2013 DA - 2013// TI - PPAR-α as a key nutritional and environmental sensor for metabolic adaption JO - Adv Nutr VL - 4 UR - https://doi.org/10.3945/an.113.003798 DO - 10.3945/an.113.003798 ID - Contreras2013 ER - TY - JOUR AU - Oliver, W. R. AU - Shenk, J. L. PY - 2001 DA - 2001// TI - A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport JO - Proc Natl Acad Sci U S A VL - 98 UR - https://doi.org/10.1073/pnas.091021198 DO - 10.1073/pnas.091021198 ID - Oliver2001 ER - TY - JOUR AU - Ajith, T. A. AU - Jayakumar, T. G. PY - 2016 DA - 2016// TI - Peroxisome proliferator-activated receptors in cardiac energy metabolism and cardiovascular disease JO - Clin Exp Pharmacol Physiol VL - 43 UR - https://doi.org/10.1111/1440-1681.12579 DO - 10.1111/1440-1681.12579 ID - Ajith2016 ER - TY - JOUR AU - Vázquez-Carrera, M. PY - 2016 DA - 2016// TI - Unraveling the effects of PPARβ/δ on insulin resistance and cardiovascular disease JO - Trends Endocrinol Metab VL - 27 UR - https://doi.org/10.1016/j.tem.2016.02.008 DO - 10.1016/j.tem.2016.02.008 ID - Vázquez-Carrera2016 ER - TY - JOUR AU - Risérus, U. AU - Sprecher, D. PY - 2008 DA - 2008// TI - Activation of peroxisome proliferator-activated receptor (PPAR) delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men JO - Diabetes VL - 57 UR - https://doi.org/10.2337/db07-1318 DO - 10.2337/db07-1318 ID - Risérus2008 ER - TY - JOUR AU - Khan, S. A. AU - Sathyanarayan, A. PY - 2015 DA - 2015// TI - ATGL-catalyzed lipolysis regulates SIRT1 to control PGC-1α/PPAR-α signaling JO - Diabetes VL - 64 UR - https://doi.org/10.2337/db14-0325 DO - 10.2337/db14-0325 ID - Khan2015 ER - TY - JOUR AU - Brown, J. M. AU - Mclntosh, M. K. PY - 2003 DA - 2003// TI - Conjugated Linoleic acid in humans: regulation of adiposity and insulin sensitivity JO - J Nutr VL - 133 ID - Brown2003 ER - TY - JOUR AU - Tang, W. H. AU - Maroo, A. PY - 2007 DA - 2007// TI - PPARgamma agonists: safety issues in heart failure JO - Diabetes Obes Metab VL - 9 UR - https://doi.org/10.1111/j.1463-1326.2006.00616.x DO - 10.1111/j.1463-1326.2006.00616.x ID - Tang2007 ER - TY - JOUR AU - Wright, M. B. AU - Bortolini, M. PY - 2014 DA - 2014// TI - Minireview: challenges and opportunities in development of PPAR agonists JO - Mol Endocrinol VL - 28 UR - https://doi.org/10.1210/me.2013-1427 DO - 10.1210/me.2013-1427 ID - Wright2014 ER - TY - JOUR AU - Jia, Z. AU - Sun, Y. PY - 2014 DA - 2014// TI - New insights into the PPARγ agonists for the treatment of diabetic nephropathy JO - PPAR Res ID - Jia2014 ER - TY - JOUR AU - Yamauchi, T. AU - Waki, H. PY - 2001 DA - 2001// TI - Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes JO - J Clin Invest VL - 108 UR - https://doi.org/10.1172/JCI12864 DO - 10.1172/JCI12864 ID - Yamauchi2001 ER -